SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Clinical trials for SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED trials appear
Sign up with your email to follow new studies for SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on viruses in cancer patients
Disease control TerminatedThis early-stage trial is testing whether genetically modified T-cells can safely control viral infections in cancer patients with weakened immune systems. The T-cells are designed to target specific viruses like CMV, BK virus, or COVID-19. The study involves 30 participants and …
Matched conditions: SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Cancer Patients' COVID-19 trial halted after just 4 volunteers
Disease control TerminatedThis early-phase study aimed to see if combining two immune-stimulating drugs (rintatolimod and interferon alpha-2b) could help cancer patients fight off COVID-19. Only 4 people took part before the study was stopped early. The main goals were to check safety and measure how the …
Matched conditions: SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC